Profiles: Page 6

The latest opinion pieces by industry thought leaders

  • A portrait of LaQuinta Jernigan framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by LaQuinta Jernigan
    Image attribution tooltip

    DE&I Champions: LaQuinta Jernigan

    The chief operating officer and ‘face’ of mdgroup is a leading voice in the efforts to diversify clinical trials.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dominique Demolle framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dominique Demolle
    Image attribution tooltip

    Tech Wizards: Dominique Demolle

    How the CEO of Cognivia is revolutionizing drug development with psychonomics.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Laura Niklason framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Laura Niklason
    Image attribution tooltip

    Entrepreneurs: Dr. Laura Niklason

    The founder, president and CEO of Humacyte is turning science fiction into regenerative medicine reality.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Judith Klimovsky framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Judith Klimovsky
    Image attribution tooltip

    Innovators: Dr. Judith Klimovsky

    The executive vice president and chief business officer of Genmab is using decades of experience in oncology R&D to fuel advances in antibody-drug conjugates. 

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Laurent Levy framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Laurent Levy
    Image attribution tooltip

    Disrupters: Laurent Levy

    Nanobiotix’s co-founder is applying the principles of nanophysics to fight cancer with a universal mechanism of action.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Jula Inrig framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Jula Inrig
    Image attribution tooltip

    Innovators: Dr. Jula Inrig

    The longtime devotee to kidney disease research is using a novel trial design to advance treatments for rare conditions at Travere.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Laxmi Bonagiri framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Laxmi Bonagiri
    Image attribution tooltip

    DE&I Champions: Laxmi Bonagiri

    EClinical Solutions’ VP of India operations is creating a path to increase the number of women in senior leadership roles while changing the course of diseases for millions.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Lisa Walters-Hoffert framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Lisa Walters-Hoffert
    Image attribution tooltip

    Entrepreneurs: Lisa Walters-Hoffert

    Daré Bioscience’s CFO and co-founder is determined to rapidly advance innovations in women’s health.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Lori Abrams framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Lori Abrams
    Image attribution tooltip

    DE&I Champions: Lori Abrams

    The VP of patient advocacy and clinical research diversity at WCG is shaking up the trial space by shining a light on underserved populations.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Michael Hayden framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Michael Hayden
    Image attribution tooltip

    Legacy Leaders: Dr. Michael Hayden

    The CEO at Prilenia has an unwavering dedication to address the needs of HD patients and their families.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Pam Diamond framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Pam Diamond
    Image attribution tooltip

    DE&I Champions: Dr. Pam Diamond

    The chief medical officer and co-founder of Curavit Clinical Research is bringing a new level of inclusiveness to clinical trials.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Dr. Mark Goldberg framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Mark Goldberg
    Image attribution tooltip

    Legacy Leaders: Dr. Mark Goldberg

    The savvy clinical trials pro has built a global CRO by targeting the needs of the industry’s bustling biotech sector.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Samantha Du framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Samantha Du
    Image attribution tooltip

    Entrepreneurs: Samantha Du

    The CEO of Zai Lab is at the forefront of the movement to boost innovation in China’s biotech sector while delivering needed solutions to patients around the world.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Mark Sullivan framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Mark Sullivan
    Image attribution tooltip

    DE&I Champions: Mark Sullivan

    Medicines Development for Global Health’s founder is committed to eliminating neglected tropical diseases around the world.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Edward Kaye framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Edward Kaye
    Image attribution tooltip

    Legacy Leaders: Dr. Edward Kaye

    The CEO behind the first genetic therapy for Duchenne muscular dystrophy is looking to extend his winning streak at Stoke.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Mary-Ann Etiebet framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Mary-Ann Etiebet
    Image attribution tooltip

    DE&I Champions: Dr. Mary-Ann Etiebet

    Merck’s associate vice president of health equity is making DE&I a part of the pharma giant's day-to-day strategy.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Elisha Hughes framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Elisha Hughes
    Image attribution tooltip

    Disrupters: Elisha Hughes

    The director of research biostatistics at Myriad Genetics is looking to stretch the boundaries of science and change how breast cancer is detected in diverse patient populations.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Matt Clark framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Matt Clark
    Image attribution tooltip

    Tech Wizards: Matt Clark

    X-Chem’s CEO has pioneered DNA-encoded libraries to revolutionize small molecule discovery.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Fahti Khosrowshahi framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Fahti Khosrowshahi
    Image attribution tooltip

    Disrupters: Fahti Khosrowshahi

    The president, CEO and founder of Ceek Women’s Health is on a mission to upend the OBGYN market.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Matt Walz framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Matt Walz
    Image attribution tooltip

    Tech Wizards: Matt Walz

    The innovative CEO is driving global clinical trial enrollment with a novel approach for the industry.   

    Meagan Parrish • Sept. 6, 2022
  • inside cell
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Leading the industry’s next potential game-changer in drug discovery

    Rachel Meyers, chief scientific officer at Faze Medicines, is helping guide the company towards the development of biomolecular condensates — an emerging field that could transform drug discovery.

    Alexandra Pecci • Aug. 29, 2022
  • Son holding father's hand at the hospital
    Image attribution tooltip
    FG Trade via Getty Images
    Image attribution tooltip

    The power of the underdog: A rare disease nonprofit working to help patients win against the odds

    Elizabeth Izard Apelles is finding innovative ways to champion rare disease patients through an emerging platform from Honeycomb Health.

    Alexandra Pecci • July 13, 2022
  • SaNOtize CEO Gilly Regev
    Image attribution tooltip
    Permission granted by SaNOtize/Gilly Regev
    Image attribution tooltip

    From vineyards to antivirals, Gilly Regev brings creative thinking to science

    The CEO of SaNOtize is tapping into outside-the-box innovation to develop a nitric oxide-delivery platform to treat and prevent COVID-19.

    Alexandra Pecci • June 27, 2022
  • Image attribution tooltip
    Michael Ciaglo / Stringer via Getty Images
    Image attribution tooltip

    Buoyed by COVID-19 shot, J&J's vaccines head sees a new golden age approaching

    Janssen’s goal to have ‘a vaccine for the world’ is part of what drew Penny Heaton to the company and its work.

    Alexandra Pecci • June 14, 2022
  • drug development
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    After losing her daughter to a rare disease, Sharon King is looking to rewrite the playbook of drug development

    The communications pro is lending her community-building, storytelling expertise to the Bespoke Gene Therapy Consortium.

    Alexandra Pecci • June 7, 2022